Farah Cadour

Cadour Farah

Medical Doctor (MD)

PhD Student

at AP-HM

Keywords

  • Heart

Publications :

180164 Cadour 1 harvard-cite-them-right-no-et-al 50 date desc year 5019 https://crmbm.univ-amu.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%223U4XKS7N%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Senlis%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSenlis%2C%20J.%2C%20Labombarda%2C%20F.%2C%20Burel%2C%20J.%2C%20Flouriot%2C%20A.%2C%20Normant%2C%20S.%2C%20Demeyere%2C%20M.%2C%20Lairez%2C%20O.%2C%20Ghannudi%2C%20S.E.%2C%20Jacquier%2C%20A.%2C%20Ghekiere%2C%20O.%2C%20Cadour%2C%20F.%20and%20Dacher%2C%20J.-N.%20%282025%29%20%26%23x201C%3BCardiac%20magnetic%20resonance%20imaging%20in%20the%20follow-up%20of%20patients%20with%20Fabry%20cardiomyopathy%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BDiagnostic%20and%20Interventional%20Imaging%26lt%3B%5C%2Fi%26gt%3B%2C%20pp.%20S2211-5684%2825%2900008%26%23x2013%3B7.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2025.02.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2025.02.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20magnetic%20resonance%20imaging%20in%20the%20follow-up%20of%20patients%20with%20Fabry%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jules%22%2C%22lastName%22%3A%22Senlis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabien%22%2C%22lastName%22%3A%22Labombarda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Burel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Flouriot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Normant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Demeyere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Lairez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soraya%20El%22%2C%22lastName%22%3A%22Ghannudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Ghekiere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Nicolas%22%2C%22lastName%22%3A%22Dacher%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20purpose%20of%20this%20study%20was%20to%20evaluate%20the%20role%20of%20cardiac%20magnetic%20resonance%20imaging%20%28MRI%29%20in%20the%20follow-up%20of%20patients%20with%20Fabry%20disease.%20Our%20hypothesis%20was%20that%20LV%20functional%20parameters%20and%20native%20myocardial%20T1%20and%20T2%20values%20could%20be%20used%20to%20monitor%20treatment%20efficacy.%5CnMATERIALS%20AND%20METHODS%3A%20This%20prospective%2C%20observational%2C%20multicenter%20study%20included%20patients%20with%20Fabry%20disease%20who%20underwent%20two%20cardiac%20MRI%20examinations%20performed%20at%201.5%20T%2024%20months%20apart%20at%20five%20University%20Hospitals%20between%20March%202017%20and%20December%202022.%20Changes%20in%20cardiac%20MRI%20parameters%20were%20compared%20between%20two%20groups%20of%20patients%20according%20to%20whether%20or%20not%20they%20were%20receiving%20specific%20treatment.%5CnRESULTS%3A%20Twenty-six%20patients%20with%20Fabry%20disease%20were%20enrolled.%20There%20were%2017%20women%20and%209%20men%2C%20with%20a%20mean%20age%20of%2045.3%20%5Cu00b1%2017.4%20%28standard%20deviation%20%5BSD%5D%29%20years.%20Both%20treated%20and%20untreated%20patients%20showed%20an%20increase%20in%20native%20T1%20values%20over%20time%2C%20but%20the%20T1%20increase%20was%20higher%20in%20treated%20patients%20%28global%20T1%2C%20%2B39.4%20%5Cu00b1%2028.9%20%5BSD%5D%20ms%29%20than%20in%20untreated%20ones%20%28global%20T1%2C%20%2B14.5%20%5Cu00b1%2030.3%20%5BSD%5D%20ms%29%20%28P%20%3D%200.04%29.%20T2%20values%20decreased%20in%20treated%20patients%20%28global%20T2%2C%20-2.11%20%5BSD%5D%20ms%20%5Cu00b1%203.36%20but%20increased%20in%20untreated%20ones%20%28global%20T2%2C%20%2B0.57%20%5Cu00b1%201.63%20%5BSD%5D%20ms%29%20%28P%20%3D%200.02%29.%20No%20significant%20changes%20in%20extracellular%20cardiac%20volume%2C%20left%20ventricular%20functional%20parameters%2C%20late%20gadolinium%20enhancement%20or%20left%20atrial%20volume%20were%20observed.%20However%2C%20LV%20mass%20index%20increased%20in%20untreated%20patients%20and%20decreased%20in%20treated%20patients.%20Intra-%20and%20interobserver%20reproducibility%20of%20T1%20measurements%20showed%20mean%20biases%20of%20-0.18%20ms%20%28limit%20of%20agreement%3A11.61%2C%2011.24%29%20and%20-0.64%20ms%20%28limit%20of%20agreement%3A23.82%3B%2022.54%29%2C%20respectively.%5CnCONCLUSION%3A%20Variations%20in%20native%20myocardial%20T1%20values%20at%20cardiac%20MRI%20are%20significantly%20greater%20in%20patients%20with%20Fabry%20disease%20receiving%20treatment%20than%20in%20untreated%20patients%2C%20suggesting%20an%20effect%20of%20treatment%20on%20lipid%20storage.%20In%20addition%2C%20changes%20in%20T2%20values%20suggest%20an%20anti-inflammatory%20effect%20of%20the%20treatment.%22%2C%22date%22%3A%222025-02-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2025.02.002%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%5D%2C%22dateModified%22%3A%222025-11-19T13%3A59%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22ERTGNHM7%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Cour%2C%20A.%2C%20Senlis%2C%20J.%2C%20Rapacchi%2C%20S.%2C%20Chennoufi%2C%20H.%2C%20Michelin%2C%20P.%2C%20McQuade%2C%20C.%2C%20Demeyere%2C%20M.%20and%20Dacher%2C%20J.-N.%20%282024%29%20%26%23x201C%3BHow%20to%20use%20MRI%20in%20cardiac%20disease%20with%20diastolic%20dysfunction%3F%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BThe%20British%20Journal%20of%20Radiology%26lt%3B%5C%2Fi%26gt%3B%2C%20p.%20tqae071.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fbjr%5C%2Ftqae071%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fbjr%5C%2Ftqae071%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22How%20to%20use%20MRI%20in%20cardiac%20disease%20with%20diastolic%20dysfunction%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Cour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jules%22%2C%22lastName%22%3A%22Senlis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislas%22%2C%22lastName%22%3A%22Rapacchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hajer%22%2C%22lastName%22%3A%22Chennoufi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Michelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22McQuade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Demeyere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Nicolas%22%2C%22lastName%22%3A%22Dacher%22%7D%5D%2C%22abstractNote%22%3A%22Left%20ventricular%20%28LV%29%20diastolic%20dysfunction%20%28DD%29%20is%20an%20initially%20asymptomatic%20condition%20that%20can%20progress%20to%20heart%20failure%2C%20either%20with%20preserved%20or%20reduced%20ejection%20fraction.%20As%20such%2C%20DD%20is%20a%20growing%20public%20health%20problem.%20Impaired%20relaxation%2C%20the%20first%20stage%20of%20DD%2C%20is%20associated%20with%20altered%20LV%20filling.%20With%20progression%2C%20reducing%20LV%20compliance%20leads%20to%20restrictive%20cardiomyopathy.%20While%20cardiac%20magnetic%20resonance%20%28CMR%29%20imaging%20is%20the%20reference%20for%20LV%20systolic%20function%20assessment%2C%20transthoracic%20echocardiography%20%28TTE%29%20with%20Doppler%20flow%20measurements%20remains%20the%20standard%20for%20diastolic%20function%20assessment.%20Rather%20than%20simply%20replicating%20TTE%20measurements%2C%20CMR%20should%20complement%20and%20further%20advance%20TTE%20findings.%20We%20provide%20herein%20a%20step-by-step%20review%20of%20CMR%20findings%20in%20DD%20as%20well%20as%20imaging%20features%20which%20may%20help%20to%20identify%20the%20underlying%20cause.%22%2C%22date%22%3A%222024-04-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbjr%5C%2Ftqae071%22%2C%22ISSN%22%3A%221748-880X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SK6VWU7K%22%5D%2C%22dateModified%22%3A%222025-09-12T07%3A59%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22FMDIVD5H%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Sourdon%2C%20J.%20and%20Rapacchi%2C%20S.%20%282024%29%20%26%23x201C%3BEditorial%20for%20%26%23x2018%3BBiventricular%20Dysfunction%20and%20Ventricular%20Interdependence%20in%20Patients%20With%20Pulmonary%20Hypertension%3A%20A%203.0-T%20Cardiac%20MRI%20Feature%20Tracking%20Study%2C%26%23x2019%3B%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Magnetic%20Resonance%20Imaging%26lt%3B%5C%2Fi%26gt%3B%2C%2060%281%29%2C%20pp.%20363%26%23x2013%3B364.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmri.29092%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmri.29092%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Editorial%20for%20%5Cu201cBiventricular%20Dysfunction%20and%20Ventricular%20Interdependence%20in%20Patients%20With%20Pulmonary%20Hypertension%3A%20A%203.0-T%20Cardiac%20MRI%20Feature%20Tracking%20Study%5Cu201d%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joevin%22%2C%22lastName%22%3A%22Sourdon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislas%22%2C%22lastName%22%3A%22Rapacchi%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fjmri.29092%22%2C%22ISSN%22%3A%221522-2586%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fjmri.29092%22%2C%22collections%22%3A%5B%22SK6VWU7K%22%2C%226B37I9FA%22%5D%2C%22dateModified%22%3A%222025-09-12T07%3A59%3A26Z%22%7D%7D%2C%7B%22key%22%3A%225BC5UBFM%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Graber%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGraber%2C%20M.%2C%20Cadour%2C%20F.%2C%20El%20Ahmadi%2C%20A.A.%2C%20Khati%2C%20I.%2C%20Del%20Grande%2C%20J.%2C%20Chagnaud%2C%20C.%2C%20Fakhry%2C%20N.%2C%20Guye%2C%20M.%20and%20Varoquaux%2C%20A.%20%282023%29%20%26%23x201C%3BAdding%20automated%20decision-tree%20models%20to%20multiparametric%20MRI%20for%20parotid%20tumours%20improves%20clinical%20performance%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BEuropean%20Journal%20of%20Radiology%26lt%3B%5C%2Fi%26gt%3B%2C%20166%2C%20p.%20110999.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejrad.2023.110999%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejrad.2023.110999%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adding%20automated%20decision-tree%20models%20to%20multiparametric%20MRI%20for%20parotid%20tumours%20improves%20clinical%20performance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Graber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%20Ali%22%2C%22lastName%22%3A%22El%20Ahmadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idir%22%2C%22lastName%22%3A%22Khati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Del%20Grande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Chagnaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Fakhry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Guye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Varoquaux%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Therapeutic%20management%20of%20parotid%20gland%20tumours%20depends%20on%20their%20histological%20type.%20To%20aid%20its%20characterisation%2C%20we%20sought%20to%20develop%20automated%20decision-tree%20models%20based%20on%20multiparametric%20magnetic%20resonance%20imaging%20%28MRI%29%20parameters%20and%20to%20evaluate%20their%20added%20diagnostic%20value%20compared%20with%20morphological%20sequences.%5CnMETHODS%3A%20206%20MRIs%20from%20206%20patients%20with%20histologically%20proven%20parotid%20gland%20tumours%20were%20included%20from%20January%202009%20to%20January%202018.%20Multiparametric%20MRI%20findings%20%28including%20parameters%20derived%20from%20diffusion-weighted%20imaging%20%5BDWI%5D%20and%20dynamic%20contrast-enhanced%20%5BDCE%5D%29%20were%20used%20to%20build%20predictive%20classification%20and%20regression%20tree%20%28CART%29%20models%20for%20each%20histological%20type.%20All%20MRIs%20were%20read%20twice%3A%20first%2C%20based%20on%20morphological%20sequence%20findings%20only%2C%20and%20second%2C%20with%20the%20addition%20of%20multiparametric%20sequences%20and%20CART%20findings.%20The%20diagnostic%20performance%20between%20these%20two%20readings%20was%20compared%20using%20ROC%20curves.%5CnRESULTS%3A%20Compared%20to%20morphological%20sequences%20alone%2C%20the%20addition%20of%20multiparametric%20analysis%20significantly%20increased%20the%20diagnostic%20performance%20for%20all%20histological%20types%20%28p%5Cu00a0%26lt%3B%5Cu00a00.001%20to%20p%5Cu00a0%3D%5Cu00a00.011%29%2C%20except%20for%20lymphomas%2C%20where%20the%20increase%20was%20not%20significant%20%28AUC%201.00%20vs.%200.99%2C%20p%5Cu00a0%3D%5Cu00a00.066%29.%20ADCmean%20was%20the%20best%20parameter%20to%20identify%20pleomorphic%20adenomas%2C%20carcinomas%20and%20lymphomas%20with%20respective%20cut-offs%20of%201.292%5Cu00a0%5Cu00d7%5Cu00a010-3%5Cu00a0mm2%5C%2Fs%2C%201.181%5Cu00a0%5Cu00d7%5Cu00a010-3%5Cu00a0mm2%5C%2Fs%20and%200.611%5Cu00a0%5Cu00d7%5Cu00a010-3%5Cu00a0mm2%5C%2Fs%2C%20respectively.%5Cu00a0%5Cu00d7%5Cu00a010-3%5Cu00a0mm2%5C%2Fs.%20The%20mean%20extracellular-extravascular%20space%20coefficient%20was%20the%20best%20parameter%20to%20Warthin%20tumours%20from%20the%20others%2C%20with%20a%20cut-off%20of%200.07.%5CnCONCLUSIONS%3A%20The%20addition%20of%20decision%20tree%20prediction%20models%20based%20on%20multiparametric%20sequences%20improves%20the%20non-invasive%20diagnostic%20performance%20of%20parotid%20gland%20tumours.%20ADC%20and%20extracellular-extravascular%20space%20coefficient%20are%20the%20two%20best%20parameters%20for%20decision%20making.%22%2C%22date%22%3A%222023-07-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ejrad.2023.110999%22%2C%22ISSN%22%3A%221872-7727%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22XTA6KS7L%22%2C%22KBIRKXGV%22%5D%2C%22dateModified%22%3A%222025-03-21T14%3A55%3A10Z%22%7D%7D%2C%7B%22key%22%3A%229Y63LXT8%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Quemeneur%2C%20M.%2C%20Biere%2C%20L.%2C%20Donal%2C%20E.%2C%20Bentatou%2C%20Z.%2C%20Eicher%2C%20J.-C.%2C%20Roubille%2C%20F.%2C%20Lalande%2C%20A.%2C%20Giorgi%2C%20R.%2C%20Rapacchi%2C%20S.%2C%20Cortaredona%2C%20S.%2C%20Tradi%2C%20F.%2C%20Bartoli%2C%20A.%2C%20Willoteaux%2C%20S.%2C%20Delahaye%2C%20F.%2C%20Biene%2C%20S.M.%2C%20Mangin%2C%20L.%2C%20Ferrier%2C%20N.%2C%20Dacher%2C%20J.-N.%2C%20Bauer%2C%20F.%2C%20Leurent%2C%20G.%2C%20Lentz%2C%20P.-A.%2C%20Kovacsik%2C%20H.%2C%20Croisille%2C%20P.%2C%20Thuny%2C%20F.%2C%20Bernard%2C%20M.%2C%20Guye%2C%20M.%2C%20Furber%2C%20A.%2C%20Habib%2C%20G.%20and%20Jacquier%2C%20A.%20%282023%29%20%26%23x201C%3BPrognostic%20value%20of%20cardiovascular%20magnetic%20resonance%20T1%20mapping%20and%20extracellular%20volume%20fraction%20in%20nonischemic%20dilated%20cardiomyopathy%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Cardiovascular%20Magnetic%20Resonance%3A%20Official%20Journal%20of%20the%20Society%20for%20Cardiovascular%20Magnetic%20Resonance%26lt%3B%5C%2Fi%26gt%3B%2C%2025%281%29%2C%20p.%207.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12968-023-00919-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12968-023-00919-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prognostic%20value%20of%20cardiovascular%20magnetic%20resonance%20T1%20mapping%20and%20extracellular%20volume%20fraction%20in%20nonischemic%20dilated%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morgane%22%2C%22lastName%22%3A%22Quemeneur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Biere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erwan%22%2C%22lastName%22%3A%22Donal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zakarya%22%2C%22lastName%22%3A%22Bentatou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Christophe%22%2C%22lastName%22%3A%22Eicher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Roubille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Lalande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roch%22%2C%22lastName%22%3A%22Giorgi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislas%22%2C%22lastName%22%3A%22Rapacchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Cortaredona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farouk%22%2C%22lastName%22%3A%22Tradi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Bartoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%22%2C%22lastName%22%3A%22Willoteaux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Delahaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20M.%22%2C%22lastName%22%3A%22Biene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lionel%22%2C%22lastName%22%3A%22Mangin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Ferrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Nicolas%22%2C%22lastName%22%3A%22Dacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Leurent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Axel%22%2C%22lastName%22%3A%22Lentz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Kovacsik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Croisille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Thuny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Guye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Furber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilbert%22%2C%22lastName%22%3A%22Habib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Heart%20failure-%20%28HF%29%20and%20arrhythmia-related%20complications%20are%20the%20main%20causes%20of%20morbidity%20and%20mortality%20in%20patients%20with%20nonischemic%20dilated%20cardiomyopathy%20%28NIDCM%29.%20Cardiovascular%20magnetic%20resonance%20%28CMR%29%20imaging%20is%20a%20noninvasive%20tool%20for%20risk%20stratification%20based%20on%20fibrosis%20assessment.%20Diffuse%20interstitial%20fibrosis%20in%20NIDCM%20may%20be%20a%20limitation%20for%20fibrosis%20assessment%20through%20late%20gadolinium%20enhancement%20%28LGE%29%2C%20which%20might%20be%20overcome%20through%20quantitative%20T1%20and%20extracellular%20volume%20%28ECV%29%20assessment.%20T1%20and%20ECV%20prognostic%20value%20for%20arrhythmia-related%20events%20remain%20poorly%20investigated.%20We%20asked%20whether%20T1%20and%20ECV%20have%20a%20prognostic%20value%20in%20NIDCM%20patients.%5CnMETHODS%3A%20This%20prospective%20multicenter%20study%20analyzed%20225%20patients%20with%20NIDCM%20confirmed%20by%20CMR%20who%20were%20followed%20up%20for%202%5Cu00a0years.%20CMR%20evaluation%20included%20LGE%2C%20native%20T1%20mapping%20and%20ECV%20values.%20The%20primary%20endpoint%20was%20the%20occurrence%20of%20a%20major%20adverse%20cardiovascular%20event%20%28MACE%29%20which%20was%20divided%20in%20two%20groups%3A%20HF-related%20events%20and%20arrhythmia-related%20events.%20Optimal%20cutoffs%20for%20prediction%20of%20MACE%20occurrence%20were%20calculated%20for%20all%20CMR%20quantitative%20values.%5CnRESULTS%3A%20Fifty-eight%20patients%20%2826%25%29%20developed%20a%20MACE%20during%20follow-up%2C%2042%20patients%20%2819%25%29%20with%20HF-related%20events%20and%2016%20patients%20%287%25%29%20arrhythmia-related%20events.%20T1%20Z-score%20%28p%5Cu2009%3D%5Cu20090.008%29%20and%20global%20ECV%20%28p%5Cu2009%3D%5Cu20090.001%29%20were%20associated%20with%20HF-related%20events%20occurrence%2C%20in%20addition%20to%20left%20ventricular%20ejection%20fraction%20%28p%5Cu2009%26lt%3B%5Cu20090.001%29.%20ECV%5Cu2009%26gt%3B%5Cu200932.1%25%20%28optimal%20cutoff%29%20remained%20the%20only%20CMR%20independent%20predictor%20of%20HF-related%20events%20occurrence%20%28HR%202.15%20%5B1.14-4.07%5D%2C%20p%5Cu2009%3D%5Cu20090.018%29.%20In%20the%20arrhythmia-related%20events%20group%2C%20patients%20had%20increased%20native%20T1%20Z-score%20and%20ECV%20values%2C%20with%20both%20T1%20Z-score%5Cu2009%26gt%3B%5Cu20094.2%20and%20ECV%5Cu2009%26gt%3B%5Cu200930.5%25%20%28optimal%20cutoffs%29%20being%20independent%20predictors%20of%20arrhythmia-related%20events%20occurrence%20%28respectively%2C%20HR%202.86%20%5B1.06-7.68%5D%2C%20p%5Cu2009%3D%5Cu20090.037%20and%20HR%202.72%20%5B1.01-7.36%5D%2C%20p%5Cu2009%3D%5Cu20090.049%29.%5CnCONCLUSIONS%3A%20ECV%20was%20the%20sole%20independent%20predictive%20factor%20for%20both%20HF-%20and%20arrhythmia-related%20events%20in%20NIDCM%20patients.%20Native%20T1%20was%20also%20an%20independent%20predictor%20in%20arrhythmia-related%20events%20occurrence.%20The%20addition%20of%20ECV%20and%20more%20importantly%20native%20T1%20in%20the%20decision-making%20algorithm%20may%20improve%20arrhythmia%20risk%20stratification%20in%20NIDCM%20patients.%20Trial%20registration%20NCT02352129.%20Registered%202nd%20February%202015-Retrospectively%20registered%2C%20https%3A%5C%2F%5C%2Fclinicaltrials.gov%5C%2Fct2%5C%2Fshow%5C%2FNCT02352129.%22%2C%22date%22%3A%222023-02-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12968-023-00919-y%22%2C%22ISSN%22%3A%221532-429X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%225Z6CVJGB%22%2C%22KFZ6H27M%22%2C%22SK6VWU7K%22%2C%22B4FUISBZ%22%2C%22XTA6KS7L%22%2C%22CXAMISN8%22%5D%2C%22dateModified%22%3A%222024-06-14T08%3A30%3A10Z%22%7D%7D%2C%7B%22key%22%3A%224QNBIIL9%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alqahtani%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAlqahtani%2C%20M.%2C%20Claudinot%2C%20A.%2C%20Gaudry%2C%20M.%2C%20Bartoli%2C%20A.%2C%20Barral%2C%20P.A.%2C%20Vidal%2C%20V.%2C%20Boyer%2C%20L.%2C%20Busa%2C%20T.%2C%20Cadour%2C%20F.%2C%20Jacquier%2C%20A.%2C%20De%20Masi%2C%20M.%20and%20Bal%2C%20L.%20%282022%29%20%26%23x201C%3BEndovascular%20Management%20of%20Vascular%20Complications%20in%20Ehlers-Danlos%20Syndrome%20Type%20IV%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%2011%2821%29%2C%20p.%206344.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fjcm11216344%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fjcm11216344%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Endovascular%20Management%20of%20Vascular%20Complications%20in%20Ehlers-Danlos%20Syndrome%20Type%20IV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mubarak%22%2C%22lastName%22%3A%22Alqahtani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amandine%22%2C%22lastName%22%3A%22Claudinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marine%22%2C%22lastName%22%3A%22Gaudry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Bartoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%20Antoine%22%2C%22lastName%22%3A%22Barral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Vidal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%22%2C%22lastName%22%3A%22Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiffany%22%2C%22lastName%22%3A%22Busa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariangela%22%2C%22lastName%22%3A%22De%20Masi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Bal%22%7D%5D%2C%22abstractNote%22%3A%22%281%29%20Background%3A%20The%20vascular%20type%20of%20Ehlers-Danlos%20syndrome%20%28vEDS%29%20is%20a%20rare%20genetic%20connective%20tissue%20disorder%20caused%20by%20pathogenic%20variants%20in%20the%20COL3A1%20gene%20that%20result%20in%20arterial%20and%20organ%20fragility%20and%20premature%20death.%20We%20present%20five%20cases%20of%20vEDS%20that%20highlight%20the%20diagnosis%20and%20treatment%20challenges%20encountered%20by%20clinicians%20with%20these%20patients.%20%282%29%20Case%20presentations%3A%20we%20present%20the%20cases%20of%20five%20patients%20with%20vascular%20complications%20of%20vEDS%20who%20were%20successfully%20managed%20using%20endovascular%20interventions%20or%20hybrid%20techniques%20at%20our%20institution%20from%202005%20to%202022.%20%283%29%20Conclusions%3A%20These%20data%20emphasize%20that%20a%20multidisciplinary%20approach%20is%20needed%20for%20vEDS%20patients%20and%20that%20when%20endovascular%20or%20hybrid%20treatment%20is%20performed%20in%20a%20timely%20manner%20by%20a%20skilled%20team%20of%20interventional%20radiologists%2C%20good%20results%20can%20be%20achieved.%20Our%20report%20also%20demonstrates%20that%20the%20prognosis%20of%20vEDS%20patients%20has%20improved%20over%20the%20past%2020%20years%20with%20a%20new%20prevention%20program%20including%20celiprolol%20therapy%2C%20physical%20activity%20adaptation%20and%20limitation%2C%20and%20scheduled%20monitoring%20by%20expert%20clinicians.%22%2C%22date%22%3A%222022-10-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fjcm11216344%22%2C%22ISSN%22%3A%222077-0383%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22CXAMISN8%22%5D%2C%22dateModified%22%3A%222024-08-27T13%3A42%3A48Z%22%7D%7D%2C%7B%22key%22%3A%2249Y55MKR%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222022-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Cautela%2C%20J.%2C%20Rapacchi%2C%20S.%2C%20Varoquaux%2C%20A.%2C%20Habert%2C%20P.%2C%20Arnaud%2C%20F.%2C%20Jacquier%2C%20A.%2C%20Meilhac%2C%20A.%2C%20Paganelli%2C%20F.%2C%20Lalev%26%23xE9%3Be%2C%20N.%2C%20Scemama%2C%20U.%20and%20Thuny%2C%20F.%20%282022%29%20%26%23x201C%3BCardiac%20MRI%20Features%20and%20Prognostic%20Value%20in%20Immune%20Checkpoint%20Inhibitor%26%23x2013%3Binduced%20Myocarditis%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BRadiology%26lt%3B%5C%2Fi%26gt%3B%2C%20303%283%29%2C%20pp.%20512%26%23x2013%3B521.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1148%5C%2Fradiol.211765%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1148%5C%2Fradiol.211765%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20MRI%20Features%20and%20Prognostic%20Value%20in%20Immune%20Checkpoint%20Inhibitor%5Cu2013induced%20Myocarditis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Cautela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislas%22%2C%22lastName%22%3A%22Rapacchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Varoquaux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Habert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Arnaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Meilhac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Paganelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Lalev%5Cu00e9e%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugo%22%2C%22lastName%22%3A%22Scemama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Thuny%22%7D%5D%2C%22abstractNote%22%3A%22Background%5Cn%5CnCardiac%20MRI%20features%20are%20not%20well-defined%20in%20immune%20checkpoint%20inhibitor%20%28ICI%29%5Cu2013induced%20myocarditis%20%28ICI-M%29%2C%20a%20severe%20complication%20of%20ICI%20therapy%20in%20patients%20with%20cancer.%5Cn%5CnPurpose%5Cn%5CnTo%20analyze%20the%20cardiac%20MRI%20features%20of%20ICI-M%20and%20to%20explore%20their%20prognostic%20value%20in%20major%20adverse%20cardiovascular%20events%20%28MACE%29.%5Cn%5CnMaterials%20and%20Methods%5Cn%5CnIn%20this%20retrospective%20study%20from%20May%202017%20to%20January%202020%2C%20cardiac%20MRI%20findings%20%28including%20late%20gadolinium%20enhancement%20%5BLGE%5D%2C%20T1%20and%20T2%20mapping%2C%20and%20extracellular%20volume%20fraction%20%5BECV%5D%20z%20scores%29%20of%20patients%20with%20ICI-M%20were%20compared%20with%20those%20of%20patients%20with%20cancer%20scheduled%20to%20receive%20ICI%20therapy%20%28pre-ICI%20group%29%20and%20patients%20with%20viral%20myocarditis.%20As%20a%20secondary%20objective%2C%20the%20potential%20value%20of%20cardiac%20MRI%20for%20predicting%20MACE%20in%20patients%20with%20ICI-M%20by%20using%20Cox%20proportional%20hazards%20models%20was%20explored.%5Cn%5CnResults%5Cn%5CnThirty-three%20patients%20with%20ICI-M%20%28mean%20age%20%5Cu00b1%20standard%20deviation%2C%2068%20years%20%5Cu00b1%2014%3B%2023%20men%29%20were%20compared%20with%2021%20patients%20scheduled%20to%20receive%20to%20ICI%20therapy%20%28mean%20age%2C%2065%20years%20%5Cu00b1%2014%3B%2014%20men%29%20and%2085%20patients%20with%20viral%20myocarditis%20%28mean%20age%2C%2032%20years%20%5Cu00b1%2013%3B%2067%20men%29.%20Compared%20with%20the%20pre-ICI%20group%2C%20patients%20with%20ICI-M%20showed%20higher%20global%20native%20T1%2C%20ECV%2C%20and%20T2%20z%20scores%20%280.03%20%5Cu00b1%200.85%20vs%201.79%20%5Cu00b1%201.93%20%5BP%20%26lt%3B%20.001%5D%3B%201.34%20%5Cu00b1%200.57%20vs%202.59%20%5Cu00b1%201.97%20%5BP%20%3D%20.03%5D%3B%20and%20%5Cu20130.76%20%5Cu00b1%201.41%20vs%200.88%20%5Cu00b1%201.96%20%5BP%20%3D%20.002%5D%2C%20respectively%29%2C%20and%20LGE%20was%20more%20frequently%20observed%20%2827%20of%2033%20patients%20%5B82%25%5D%20vs%20two%20of%2021%20%5B10%25%5D%3B%20P%20%26lt%3B%20.001%29.%20LGE%20was%20less%20frequent%20in%20patients%20with%20ICI-M%20than%20those%20with%20viral%20myocarditis%20%2827%20of%2033%20patients%20%5B82%25%5D%20vs%2085%20of%2085%20%5B100%25%5D%3B%20P%20%26lt%3B%20.001%29%20but%20was%20more%20likely%20to%20involve%20the%20septal%20segments%20%2816%20of%2033%20patients%20%5B48%25%5D%20vs%2025%20of%2085%20%5B29%25%5D%3B%20P%20%26lt%3B%20.001%29%20and%20midwall%20layer%20%2811%20of%2033%20patients%20%5B33%25%5D%20vs%20two%20of%2085%20%5B2%25%5D%3B%20P%20%26lt%3B%20.001%29.%20Septal%20LGE%20was%20the%20only%20cardiac%20MRI%20predictor%20of%20MACE%20at%201%20year%20even%20after%20adjustment%20for%20peak%20troponin%20%28adjusted%20hazard%20ratio%2C%202.7%20%5B95%25%20CI%3A%201.1%2C%206.7%5D%3B%20P%20%3D%20.03%29.%5Cn%5CnConclusion%5Cn%5CnCardiac%20MRI%20features%20of%20immune%20checkpoint%20inhibitor%20%28ICI%29%5Cu2013induced%20myocarditis%20%28ICI-M%29%20seem%20to%20differ%20from%20those%20in%20patients%20scheduled%20to%20receive%20ICIs%20and%20patients%20with%20viral%20myocarditis.%20Septal%20late%20gadolinium%20enhancement%20might%20be%20a%20predictor%20of%20major%20cardiovascular%20events%20in%20patients%20with%20ICI-M.%5Cn%5CnClinical%20trial%20registration%20no.%20NCT03313544%5Cn%5Cn%5Cu00a9%20RSNA%2C%202022%5Cn%5CnOnline%20supplemental%20material%20is%20available%20for%20this%20article.%5Cn%5CnSee%20also%20the%20editorial%20by%20Edelman%20and%20Pursnani%20in%20this%20issue.%22%2C%22date%22%3A%222022-06%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1148%5C%2Fradiol.211765%22%2C%22ISSN%22%3A%220033-8419%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubs.rsna.org%5C%2Fdoi%5C%2F10.1148%5C%2Fradiol.211765%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22SK6VWU7K%22%2C%22KBIRKXGV%22%5D%2C%22dateModified%22%3A%222025-03-19T13%3A32%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22QCUNRZUF%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Silhol%2C%20F.%2C%20Iline%2C%20N.%2C%20Giorgi%2C%20R.%2C%20Lorthioir%2C%20A.%2C%20Amar%2C%20L.%2C%20Sapoval%2C%20M.%2C%20Rousseau%2C%20H.%2C%20Sarlon%2C%20G.%2C%20Thony%2C%20F.%20and%20Jacquier%2C%20A.%20%282022%29%20%26%23x201C%3BInsights%20from%20intravascular%20pressure%20measurement%20of%20renal%20artery%20revascularization%20in%20patients%20with%20fibromuscular%20dysplasia%3A%20The%20DYSART%20study%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Vascular%20Surgery%26lt%3B%5C%2Fi%26gt%3B%2C%2075%283%29%2C%20pp.%20939-949.e1.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvs.2021.09.023%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvs.2021.09.023%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Insights%20from%20intravascular%20pressure%20measurement%20of%20renal%20artery%20revascularization%20in%20patients%20with%20fibromuscular%20dysplasia%3A%20The%20DYSART%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Silhol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Iline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roch%22%2C%22lastName%22%3A%22Giorgi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lien%22%2C%22lastName%22%3A%22Lorthioir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Amar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Sapoval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herv%5Cu00e9%22%2C%22lastName%22%3A%22Rousseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabrielle%22%2C%22lastName%22%3A%22Sarlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Thony%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-03-01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jvs.2021.09.023%22%2C%22ISSN%22%3A%220741-5214%2C%201097-6809%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.jvascsurg.org%5C%2Farticle%5C%2FS0741-5214%2821%2902180-7%5C%2Ffulltext%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22TXRC8BWU%22%5D%2C%22dateModified%22%3A%222024-11-21T08%3A41%3A14Z%22%7D%7D%2C%7B%22key%22%3A%227IQRB4JV%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pirocca%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPirocca%2C%20U.%2C%20Hadouiri%2C%20N.%2C%20Bartoli%2C%20A.%2C%20Morcet-Delattre%2C%20T.%2C%20Pontana%2C%20F.%2C%20Cochet%2C%20H.%2C%20Tacher%2C%20V.%2C%20Cadour%2C%20F.%2C%20Mandry%2C%20D.%20and%20Jacquier%2C%20A.%20%282022%29%20%26%23x201C%3BHow%20attractive%20is%20cardiac%20imaging%20to%20French%20radiology%20residents%3F%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BDiagnostic%20and%20Interventional%20Imaging%26lt%3B%5C%2Fi%26gt%3B%2C%20103%283%29%2C%20pp.%20185%26%23x2013%3B188.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2021.12.004%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2021.12.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22How%20attractive%20is%20cardiac%20imaging%20to%20French%20radiology%20residents%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugo%22%2C%22lastName%22%3A%22Pirocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nawale%22%2C%22lastName%22%3A%22Hadouiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Bartoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibaud%22%2C%22lastName%22%3A%22Morcet-Delattre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Pontana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hubert%22%2C%22lastName%22%3A%22Cochet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vania%22%2C%22lastName%22%3A%22Tacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%22%2C%22lastName%22%3A%22Mandry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2021.12.004%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%5D%2C%22dateModified%22%3A%222024-04-25T13%3A11%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22DTTG9UG7%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bartoli%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBartoli%2C%20A.%2C%20Fournel%2C%20J.%2C%20Ait-Yahia%2C%20L.%2C%20Cadour%2C%20F.%2C%20Tradi%2C%20F.%2C%20Ghattas%2C%20B.%2C%20Cortaredona%2C%20S.%2C%20Million%2C%20M.%2C%20Lasbleiz%2C%20A.%2C%20Dutour%2C%20A.%2C%20Gaborit%2C%20B.%20and%20Jacquier%2C%20A.%20%282022%29%20%26%23x201C%3BAutomatic%20Deep-Learning%20Segmentation%20of%20Epicardial%20Adipose%20Tissue%20from%20Low-Dose%20Chest%20CT%20and%20Prognosis%20Impact%20on%20COVID-19%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BCells%26lt%3B%5C%2Fi%26gt%3B%2C%2011%286%29%2C%20p.%201034.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells11061034%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells11061034%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Automatic%20Deep-Learning%20Segmentation%20of%20Epicardial%20Adipose%20Tissue%20from%20Low-Dose%20Chest%20CT%20and%20Prognosis%20Impact%20on%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Bartoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joris%22%2C%22lastName%22%3A%22Fournel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%5Cu00e9a%22%2C%22lastName%22%3A%22Ait-Yahia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farouk%22%2C%22lastName%22%3A%22Tradi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Badih%22%2C%22lastName%22%3A%22Ghattas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Cortaredona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Million%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ad%5Cu00e8le%22%2C%22lastName%22%3A%22Lasbleiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Dutour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9n%5Cu00e9dicte%22%2C%22lastName%22%3A%22Gaborit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20To%20develop%20a%20deep-learning%20%28DL%29%20pipeline%20that%20allowed%20an%20automated%20segmentation%20of%20epicardial%20adipose%20tissue%20%28EAT%29%20from%20low-dose%20computed%20tomography%20%28LDCT%29%20and%20investigate%20the%20link%20between%20EAT%20and%20COVID-19%20clinical%20outcomes.%20Methods%3A%20This%20monocentric%20retrospective%20study%20included%20353%20patients%3A%2095%20for%20training%2C%2020%20for%20testing%2C%20and%20238%20for%20prognosis%20evaluation.%20EAT%20segmentation%20was%20obtained%20after%20thresholding%20on%20a%20manually%20segmented%20pericardial%20volume.%20The%20model%20was%20evaluated%20with%20Dice%20coefficient%20%28DSC%29%2C%20inter-and%20intraobserver%20reproducibility%2C%20and%20clinical%20measures.%20Uni-and%20multi-variate%20analyzes%20were%20conducted%20to%20assess%20the%20prognosis%20value%20of%20the%20EAT%20volume%2C%20EAT%20extent%2C%20and%20lung%20lesion%20extent%20on%20clinical%20outcomes%2C%20including%20hospitalization%2C%20oxygen%20therapy%2C%20intensive%20care%20unit%20admission%20and%20death.%20Results%3A%20The%20mean%20DSC%20for%20EAT%20volumes%20was%200.85%20%5Cu00b1%200.05.%20For%20EAT%20volume%2C%20the%20mean%20absolute%20error%20was%2011.7%20%5Cu00b1%208.1%20cm3%20with%20a%20non-significant%20bias%20of%20%5Cu22124.0%20%5Cu00b1%2013.9%20cm3%20and%20a%20correlation%20of%200.963%20with%20the%20manual%20measures%20%28p%20%26lt%3B%200.01%29.%20The%20multivariate%20model%20providing%20the%20higher%20AUC%20to%20predict%20adverse%20outcome%20include%20both%20EAT%20extent%20and%20lung%20lesion%20extent%20%28AUC%20%3D%200.805%29.%20Conclusions%3A%20A%20DL%20algorithm%20was%20developed%20and%20evaluated%20to%20obtain%20reproducible%20and%20precise%20EAT%20segmentation%20on%20LDCT.%20EAT%20extent%20in%20association%20with%20lung%20lesion%20extent%20was%20associated%20with%20adverse%20clinical%20outcomes%20with%20an%20AUC%20%3D%200.805.%22%2C%22date%22%3A%222022%5C%2F1%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fcells11061034%22%2C%22ISSN%22%3A%222073-4409%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2073-4409%5C%2F11%5C%2F6%5C%2F1034%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22CXAMISN8%22%5D%2C%22dateModified%22%3A%222025-11-27T10%3A53%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22VSF3I3KY%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Thuny%2C%20F.%20and%20Sourdon%2C%20J.%20%282022%29%20%26%23x201C%3BNew%20Insights%20in%20Early%20Detection%20of%20Anticancer%20Drug-Related%20Cardiotoxicity%20Using%20Perfusion%20and%20Metabolic%20Imaging%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Cardiovascular%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%209%2C%20p.%20813883.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2022.813883%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2022.813883%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22New%20Insights%20in%20Early%20Detection%20of%20Anticancer%20Drug-Related%20Cardiotoxicity%20Using%20Perfusion%20and%20Metabolic%20Imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Thuny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joevin%22%2C%22lastName%22%3A%22Sourdon%22%7D%5D%2C%22abstractNote%22%3A%22Cardio-oncology%20requires%20a%20good%20knowledge%20of%20the%20cardiotoxicity%20of%20anticancer%20drugs%2C%20their%20mechanisms%2C%20and%20their%20diagnosis%20for%20better%20management.%20Anthracyclines%2C%20anti-vascular%20endothelial%20growth%20factor%20%28VEGF%29%2C%20alkylating%20agents%2C%20antimetabolites%2C%20anti-human%20epidermal%20growth%20factor%20receptor%20%28HER%29%2C%20and%20receptor%20tyrosine%20kinase%20inhibitors%20%28RTKi%29%20are%20therapeutics%20whose%20cardiotoxicity%20involves%20several%20mechanisms%20at%20the%20cellular%20and%20subcellular%20levels.%20Current%20guidelines%20for%20anticancer%20drugs%20cardiotoxicity%20are%20essentially%20based%20on%20monitoring%20left%20ventricle%20ejection%20fraction%20%28LVEF%29.%20However%2C%20knowledge%20of%20microvascular%20and%20metabolic%20dysfunction%20allows%20for%20better%20imaging%20assessment%20before%20overt%20LVEF%20impairment.%20Early%20detection%20of%20anticancer%20drug-related%20cardiotoxicity%20would%20therefore%20advance%20the%20prevention%20and%20patient%20care.%20In%20this%20review%2C%20we%20provide%20a%20comprehensive%20overview%20of%20the%20cardiotoxic%20effects%20of%20anticancer%20drugs%20and%20describe%20myocardial%20perfusion%2C%20metabolic%2C%20and%20mitochondrial%20function%20imaging%20approaches%20to%20detect%20them%20before%20over%20LVEF%20impairment.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffcvm.2022.813883%22%2C%22ISSN%22%3A%222297-055X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226B37I9FA%22%5D%2C%22dateModified%22%3A%222024-04-25T13%3A11%3A13Z%22%7D%7D%2C%7B%22key%22%3A%222FR7BTCZ%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222020-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20Tradi%2C%20F.%2C%20Habert%2C%20P.%2C%20Scemama%2C%20U.%2C%20Vidal%2C%20V.%2C%20Jacquier%2C%20A.%2C%20Bartoli%2C%20J.-M.%2C%20Moulin%2C%20G.%20and%20Bessayah%2C%20A.%20%282020%29%20%26%23x201C%3BProstatic%20artery%20embolization%20using%20three-dimensional%20cone-beam%20computed%20tomography%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BDiagnostic%20and%20Interventional%20Imaging%26lt%3B%5C%2Fi%26gt%3B%2C%20101%2811%29%2C%20pp.%20721%26%23x2013%3B725.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2020.05.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2020.05.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prostatic%20artery%20embolization%20using%20three-dimensional%20cone-beam%20computed%20tomography%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Tradi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Habert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Scemama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Vidal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-M.%22%2C%22lastName%22%3A%22Bartoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bessayah%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20purpose%20of%20this%20study%20was%20to%20report%20the%20use%20of%20three-dimensional%20%283D%29%20cone-beam%20computed%20tomography%20%28CBCT%29%20for%20prostatic%20artery%20embolization%20%28PAE%29%20in%20patients%20with%20benign%20prostatic%20hypertrophy%20%28BPH%29.%5CnMATERIALS%20AND%20METHODS%3A%20Twenty-three%20consecutive%20men%20who%20underwent%20PAE%20using%203D%20CBCT%20from%20June%202016%20to%20September%202018%2C%20were%20retrospectively%20included%20in%20this%20observational%20single-center%20study.%20There%20were%2023%20men%20with%20a%20mean%20age%20of%2073%5Cu00b112%20%28SD%29%20years%20%28range%3A%2052-94years%29%20with%20moderate%20to%20severe%20lower%20urinary%20tract%20symptoms%20%28mean%20international%20prostate%20symptom%20score%2C%2021%5Cu00b15.7%20%5BSD%5D%3B%20range%3A%209-30%29%20due%20to%20BPH%20%28mean%20prostate%20weight%2C%20100g%5Cu00b163%20%5BSD%5D%3B%20range%3A%2030-250g%29.%20PAEs%20were%20analyzed%20with%20respect%20to%20procedure%20time%2C%20fluoroscopy%20time%2C%20technical%20success%2C%20complications%20and%20dosimetric%20indices.%5CnRESULTS%3A%20The%20mean%20catheterization%20time%20of%20the%20prostatic%20artery%20from%20the%20internal%20iliac%20artery%20was%2017.3%5Cu00b112.5%20%28SD%29%20min%20%28range%3A%208-57min%29%20on%20the%20right%20side%20and%2023.6%5Cu00b114.9%20%28SD%29%20min%20%28range%3A%206-54min%29%20on%20the%20left%20side.%20A%20technical%20success%20was%20achieved%20in%2021%20patients%20%2821%5C%2F23%3B%2091%25%29.%20PAE%20was%20bilateral%20in%2014%20patients%20%2814%5C%2F21%3B%2066%25%29%20and%20unilateral%20in%207%20patients%20%287%5C%2F21%3B%2033%25%29.%20No%20occurrence%20of%20non-target%20embolization%20was%20reported.%20The%20mean%20dose%20area%20product%20was%20146.7%5Cu00b147.9%20%28SD%29%20Gy.cm2%20%28range%3A%2054-254Gy.cm2%29%20and%20mean%20cumulative%20air%20kerma%20was%20771.4%5Cu00b1333.3%20%28SD%29%20mGy%3B%20range%3A%20280-1560%20mGy.%20The%20mean%20fluoroscopy%20time%20was%2042.3%5Cu00b123.1%20%28SD%29%20min%20%28range%3A%2019.4-118.2min%29.%5CnCONCLUSION%3A%203D%20CBCT%20is%20a%20useful%20tool%20to%20identify%20the%20prostatic%20arteries%20and%20facilitates%20catheterization%20of%20prostatic%20arteries%20with%20an%20acceptable%20level%20of%20radiation%20exposure.%22%2C%22date%22%3A%222020-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2020.05.002%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22TXRC8BWU%22%5D%2C%22dateModified%22%3A%222024-04-25T13%3A11%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22APM2Q8ZH%22%2C%22library%22%3A%7B%22id%22%3A180164%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadour%20et%20al.%22%2C%22parsedDate%22%3A%222019-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCadour%2C%20F.%2C%20De%20Masi-Jacquier%2C%20M.%2C%20Barral%2C%20P.-A.%2C%20Cammilleri%2C%20S.%2C%20Jacquier%2C%20A.%20and%20Bal%2C%20L.%20%282019%29%20%26%23x201C%3BThoracic%20Aortic%20Aneurysms%20and%20Erdheim-Chester%20Disease%2C%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20vascular%20and%20interventional%20radiology%3A%20JVIR%26lt%3B%5C%2Fi%26gt%3B%2C%2030%2810%29%2C%20pp.%201698%26%23x2013%3B1700.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvir.2019.01.020%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvir.2019.01.020%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Thoracic%20Aortic%20Aneurysms%20and%20Erdheim-Chester%20Disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farah%22%2C%22lastName%22%3A%22Cadour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariangela%22%2C%22lastName%22%3A%22De%20Masi-Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Antoine%22%2C%22lastName%22%3A%22Barral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%22%2C%22lastName%22%3A%22Cammilleri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Bal%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jvir.2019.01.020%22%2C%22ISSN%22%3A%221535-7732%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KFZ6H27M%22%2C%22TXRC8BWU%22%5D%2C%22dateModified%22%3A%222024-08-27T13%3A42%3A50Z%22%7D%7D%5D%7D
Senlis, J., Labombarda, F., Burel, J., Flouriot, A., Normant, S., Demeyere, M., Lairez, O., Ghannudi, S.E., Jacquier, A., Ghekiere, O., Cadour, F. and Dacher, J.-N. (2025) “Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy,” Diagnostic and Interventional Imaging, pp. S2211-5684(25)00008–7. Available at: https://doi.org/10.1016/j.diii.2025.02.002.
Cadour, F., Cour, A., Senlis, J., Rapacchi, S., Chennoufi, H., Michelin, P., McQuade, C., Demeyere, M. and Dacher, J.-N. (2024) “How to use MRI in cardiac disease with diastolic dysfunction?,” The British Journal of Radiology, p. tqae071. Available at: https://doi.org/10.1093/bjr/tqae071.
Cadour, F., Sourdon, J. and Rapacchi, S. (2024) “Editorial for ‘Biventricular Dysfunction and Ventricular Interdependence in Patients With Pulmonary Hypertension: A 3.0-T Cardiac MRI Feature Tracking Study,’” Journal of Magnetic Resonance Imaging, 60(1), pp. 363–364. Available at: https://doi.org/10.1002/jmri.29092.
Graber, M., Cadour, F., El Ahmadi, A.A., Khati, I., Del Grande, J., Chagnaud, C., Fakhry, N., Guye, M. and Varoquaux, A. (2023) “Adding automated decision-tree models to multiparametric MRI for parotid tumours improves clinical performance,” European Journal of Radiology, 166, p. 110999. Available at: https://doi.org/10.1016/j.ejrad.2023.110999.
Cadour, F., Quemeneur, M., Biere, L., Donal, E., Bentatou, Z., Eicher, J.-C., Roubille, F., Lalande, A., Giorgi, R., Rapacchi, S., Cortaredona, S., Tradi, F., Bartoli, A., Willoteaux, S., Delahaye, F., Biene, S.M., Mangin, L., Ferrier, N., Dacher, J.-N., Bauer, F., Leurent, G., Lentz, P.-A., Kovacsik, H., Croisille, P., Thuny, F., Bernard, M., Guye, M., Furber, A., Habib, G. and Jacquier, A. (2023) “Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy,” Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance, 25(1), p. 7. Available at: https://doi.org/10.1186/s12968-023-00919-y.
Alqahtani, M., Claudinot, A., Gaudry, M., Bartoli, A., Barral, P.A., Vidal, V., Boyer, L., Busa, T., Cadour, F., Jacquier, A., De Masi, M. and Bal, L. (2022) “Endovascular Management of Vascular Complications in Ehlers-Danlos Syndrome Type IV,” Journal of Clinical Medicine, 11(21), p. 6344. Available at: https://doi.org/10.3390/jcm11216344.
Cadour, F., Cautela, J., Rapacchi, S., Varoquaux, A., Habert, P., Arnaud, F., Jacquier, A., Meilhac, A., Paganelli, F., Lalevée, N., Scemama, U. and Thuny, F. (2022) “Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor–induced Myocarditis,” Radiology, 303(3), pp. 512–521. Available at: https://doi.org/10.1148/radiol.211765.
Cadour, F., Silhol, F., Iline, N., Giorgi, R., Lorthioir, A., Amar, L., Sapoval, M., Rousseau, H., Sarlon, G., Thony, F. and Jacquier, A. (2022) “Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study,” Journal of Vascular Surgery, 75(3), pp. 939-949.e1. Available at: https://doi.org/10.1016/j.jvs.2021.09.023.
Pirocca, U., Hadouiri, N., Bartoli, A., Morcet-Delattre, T., Pontana, F., Cochet, H., Tacher, V., Cadour, F., Mandry, D. and Jacquier, A. (2022) “How attractive is cardiac imaging to French radiology residents?,” Diagnostic and Interventional Imaging, 103(3), pp. 185–188. Available at: https://doi.org/10.1016/j.diii.2021.12.004.
Bartoli, A., Fournel, J., Ait-Yahia, L., Cadour, F., Tradi, F., Ghattas, B., Cortaredona, S., Million, M., Lasbleiz, A., Dutour, A., Gaborit, B. and Jacquier, A. (2022) “Automatic Deep-Learning Segmentation of Epicardial Adipose Tissue from Low-Dose Chest CT and Prognosis Impact on COVID-19,” Cells, 11(6), p. 1034. Available at: https://doi.org/10.3390/cells11061034.
Cadour, F., Thuny, F. and Sourdon, J. (2022) “New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging,” Frontiers in Cardiovascular Medicine, 9, p. 813883. Available at: https://doi.org/10.3389/fcvm.2022.813883.
Cadour, F., Tradi, F., Habert, P., Scemama, U., Vidal, V., Jacquier, A., Bartoli, J.-M., Moulin, G. and Bessayah, A. (2020) “Prostatic artery embolization using three-dimensional cone-beam computed tomography,” Diagnostic and Interventional Imaging, 101(11), pp. 721–725. Available at: https://doi.org/10.1016/j.diii.2020.05.002.
Cadour, F., De Masi-Jacquier, M., Barral, P.-A., Cammilleri, S., Jacquier, A. and Bal, L. (2019) “Thoracic Aortic Aneurysms and Erdheim-Chester Disease,” Journal of vascular and interventional radiology: JVIR, 30(10), pp. 1698–1700. Available at: https://doi.org/10.1016/j.jvir.2019.01.020.